Aligos TherapeuticsALGS
13F holders, Q1 2024 (March 31)49holders
3famous investors
$0.98avg. 13F price*
At the end of Q1 2024, 49 institutions reported holding Aligos Therapeutics Inc. (ALGS) in their 13F filings. The largest holders were Armistice Capital, LLC ($6.8M), EcoR1 Capital, LLC ($6.3M) and Deep Track Capital, LP ($6.0M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aligos Therapeutics Inc.
- CUSIP
- 01626L105
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $3.3M |
| Exits | 2 | $1.9M |
Ownership 49 holders
| Armistice Capital, LLC | 0.18% | Add +0.9% | 6,893,410 | $6.8M |
| EcoR1 Capital, LLC | 0.16% | No change | 6,389,468 | $6.3M |
| Deep Track Capital, LP | 0.17% | No change | 6,102,770 | $6.0M |
| Vivo Capital, LLC | 0.27% | No change | 3,547,030 | $3.5M |
| Altitude Crest Partners Inc. | 1.19% | No change | 2,844,681 | $2.8M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | New | 2,464,505 | $2.4M |
| Versant Venture Management, LLC | 2.20% | No change | 2,320,381 | $2.3M |
| Baker Bros. Advisors LP | 0.03% | No change | 2,076,400 | $2.0M |
| HHLR Advisors, LTD. | 0.04% | No change | 1,906,191 | $1.9M |
| Tang Capital Management LLC | 0.17% | Reduce -24.6% | 1,650,000 | $1.6M |
| Opaleye Management Inc. | 0.35% | Add +25.7% | 1,630,000 | $1.6M |
| Newtyn Management, LLC | 0.24% | Reduce -4.4% | 1,200,000 | $1.2M |
| Bank of America Corp. | 0.00% | Reduce 0.0% | 1,147,727 | $1.1M |
| Vanguard Group Inc. | 0.00% | Add +0.1% | 1,013,067 | $993K |
| Renaissance Technologies | 0.00% | Add +65.0% | 808,260 | $792K |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.47% | No change | 743,215 | $728K |
| Acadian Asset Management LLC | 0.00% | Add +17.6% | 657,995 | $644K |
| Silverarc Capital Management, LLC | 0.18% | Reduce -1.9% | 655,515 | $642K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | New | 500,000 | $490K |
| Geode Capital Management, LLC | 0.00% | Add +16.2% | 373,056 | $366K |
| BlackRock Inc. | 0.00% | Add +2.6% | 303,755 | $298K |
| Citadel Advisors | 0.00% | New | 285,679 | $280K |
| Millennium Management | 0.00% | Add +285.5% | 110,661 | $108K |
| State Street Corp. | 0.00% | No change | 97,423 | $95K |
| Northern Trust Corp. | 0.00% | Add +70.5% | 92,015 | $90K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 92,000 | $90K |
| XTX Topco Ltd | 0.01% | Add +74.3% | 44,871 | $44K |
| Atom Investors LP | 0.00% | New | 34,173 | $33K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 31,383 | $31K |
| Choate Investment Advisors | 0.00% | No change | 24,000 | $24K |
| Procyon Advisors, LLC | 0.00% | New | 20,000 | $20K |
| HarbourVest Partners LLC | 0.01% | No change | 18,783 | $18K |
| Two Sigma Investments, LP | 0.00% | No change | 18,624 | $18K |
| Cwm, LLC | 0.00% | No change | 16,891 | $17K |
| Creative Planning | 0.00% | Add +54.5% | 15,525 | $15K |
| ZWJ Investment Counsel Inc. | 0.00% | New | 14,500 | $14K |
| Zullo Investment Group, Inc. | 0.01% | No change | 13,000 | $13K |
| Vontobel Holding Ltd. | 0.00% | New | 12,500 | $12K |
| UBS Group AG | 0.00% | New | 10,825 | $11K |
| Total Clarity Wealth Management, Inc. | 0.00% | New | 10,000 | $10K |
| Financial Advocates Investment Management | 0.00% | New | 10,000 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -57.2% | 8,022 | $8K |
| Morgan Stanley | 0.00% | Add +65.0% | 3,300 | $3K |
| Simplex Trading, LLC | 0.00% | New | 1,104 | $1K |
| JPMorgan Chase & Co. | 0.00% | No change | 677 | $663 |
| Wells Fargo & Company | 0.00% | Add +1.7% | 298 | $292 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 100 | $98 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -71.9% | 124 | $0 |
"% of holder's portfolio" is ALGS's weight in each manager's 13F, not the share of Aligos Therapeutics Inc. the manager owns.